Overview
Salaries
Products
People
Growth
Offices
Financials

Overview

Eikonoklastes Therapeutics is rapidly developing disruptive treatments for today’s most challenging diseases.

People

Bruce Halpryn
Executive Officer, Director
Samuel Lee
Executive Officer, Director
Kenneth Morand
Director
Thomas Finn
Director
Robert Johnson
Director
Joseph Nolan
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Cincinnati United States
HQ
50-200 est. staff

Financials

Total raised
$27.5M
Latest round
Venture - Series Unknown
Funding rounds
6
Funding rounds
Round Announced Amount
Venture - Series Unknown 2025 $16.1M Details
Debt Financing 2024 $2.4M Details
Debt Financing 2023 $2M Details
Debt Financing 2021 $2.8M Details
Venture - Series Unknown 2021 $3.2M Details
Venture - Series Unknown 2020 $1.1M Details